Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

VRXA vs PMAX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PMAX Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 6–2 Matrix Metrics)

PMAX Overall Winner 6-Pillar Tally: VRXA 0 – 4 PMAX (2 Tie) Matrix Metrics: VRXA 2 – 6 PMAX

As of Nov 20, 2026, Powell Max Limited Class A (PMAX) is the stronger overall head-to-head candidate over VRXA (VRXA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VRXA carries a Unified Composite Score of 41.6/100 (SELL) at $1.04 (N/M Forward P/E, N/A operating margin), whereas PMAX carries 37.0/100 (SELL) at $0.56 (N/M Forward P/E, -24.9% operating margin).

  • Composite vs. Pillar Nuance: While VRXA currently prints a higher short-term Unified Composite Score (41.6/100 SELL vs. PMAX 37.0/100 SELL), PMAX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24.9% vs. N/A operating margin) and revenue trajectory (+72.7% vs. N/A YoY).
  • Defensive Composite Rating Caution: Although PMAX compares more favorably head-to-head, both VRXA (41.6/100 SELL) and PMAX (37.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: VRXA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.0); meanwhile PMAX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VRXA vs PMAX
VRXA US Equity
VRXA
Institutional Equity
$1.04
+0.97% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.16β · 104% Vol
Unified Composite Score
41.6 / 100 SELL
Tech 30.0 Fund 41.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.0 · SMA20: $1.04 · SMA50: $1.17
PMAX NASDAQ Head-to-Head Winner
Powell Max Limited Class A Ordinary Shares
Services-Miscellaneous Business Services
$0.56
-8.16% 1D
Market Cap $2.2M
TTM Revenue $48M
Forward P/E N/M
Beta / 30D Vol 10.65β · 239% Vol
Unified Composite Score
37.0 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -18.1%), weak momentum, RSI 41
RSI-14: 41.4 · SMA20: $0.66 · SMA50: $0.77

6-Pillar Scorecard Institutional Category Breakdown (VRXA 0 – 4 PMAX)

Columns: Metric · VRXA · PMAX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale PMAX
Revenue Growth (YoY) N/A +72.7%
Earnings Growth (YoY) N/A -78.7%
TTM Revenue (USD) N/A $48M
Market Cap N/A $2.2M
3. Profitability & Quality PMAX
Gross Margin N/A 49.5%
Operating Margin N/A -24.9%
Net Profit Margin N/A -49.3%
Return on Equity (ROE) N/A -101.8%
4. Balance Sheet & Cash Flow PMAX
Cash Generation (TTM) N/A -$8.3M EBITDA
Cash Flow Margin N/A -17.3% EBITDA Mgn
Net Cash / Leverage N/A ROE $11.98 Book/Sh · -101.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat PMAX
OpEx & R&D Intensity N/A 74.4% of Rev ($35M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VRXA (2) vs PMAX (6)
Institutional Metric VRXA PMAX Criterion Row Edge
Market Capitalization
Scale
N/A $2.2M Larger Scale PMAX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +72.7% Higher Growth PMAX
Operating Margin (TTM)
Profitability
N/A -24.9% Higher Margin PMAX
Net Profit Margin
Profitability
N/A -49.3% Higher Margin PMAX
Return on Equity (ROE)
Capital Efficiency
N/A -101.8% Higher ROE PMAX
52-Week Range Position
Momentum
0% ($1–$27) 8% ($0–$5) Stronger Trend PMAX
Beta / 30D Volatility
Risk Regime
1.16β · 104% Vol 10.65β · 239% Vol Lower Realized Risk VRXA
Unified Institutional Score
Composite Signal
41.6 / 100 (SELL) 37.0 / 100 (SELL) Higher Composite VRXA
Trailing 12M Revenue (USD)
Operating Scale
N/A $48M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 49.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$8.3M EBITDA ($11.98 Book/Sh · -101.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PMAX +15.59 pp
VRXA: +0.97% · PMAX: +16.56%
3M Horizon VRXA +11.75 pp
VRXA: -41.57% · PMAX: -53.32%
6M Horizon PMAX +24.09 pp
VRXA: -95.8% · PMAX: -71.71%
1Y Horizon PMAX +24.09 pp
VRXA: -95.8% · PMAX: -71.71%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VRXA vs PMAX. Trailing 12-month operating profitability (VRXA N/A vs PMAX -24.9%) and valuation multiples (VRXA N/M vs PMAX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

VRXA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PMAX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$48M
Gross Margin49.5%
Op. Margin-24.9%
ROE / Fwd P/E-101.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VRXA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VRXA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PMAX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PMAX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VRXA Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PMAX Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $2.2M market capitalization and -24.9% operating margin.
OpEx & R&D Reinvestment 74.4% of Rev ($35M)
90D Engineering Disclosures 0 Published

Investor FAQ VRXA vs PMAX Key Questions & Quantitative Answers

As of Nov 20, 2026, Powell Max Limited Class A (PMAX) is the stronger overall head-to-head candidate over VRXA (VRXA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VRXA carries a Unified Composite Score of 41.6/100 (SELL) at $1.04 (N/M Forward P/E, N/A operating margin), whereas PMAX carries 37.0/100 (SELL) at $0.56 (N/M Forward P/E, -24.9% operating margin). Composite vs. Pillar Nuance: While VRXA currently prints a higher short-term Unified Composite Score (41.6/100 SELL vs. PMAX 37.0/100 SELL), PMAX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24.9% vs. N/A operating margin) and revenue trajectory (+72.7% vs. N/A YoY). Defensive Composite Rating Caution: Although PMAX compares more favorably head-to-head, both VRXA (41.6/100 SELL) and PMAX (37.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: VRXA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.0); meanwhile PMAX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PMAX leads the Growth & Scale pillar: VRXA posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PMAX at +72.7% YoY revenue growth and -78.7% YoY earnings growth on $48M TTM revenue (49.5% gross margin, -24.9% operating margin). On trailing 12-month operating scale, VRXA generates N/A in USD-normalized revenue versus $48M for PMAX. In operating R&D and SG&A reinvestment, VRXA deploys N/A (0 90-day corporate R&D disclosures) versus 74.4% of Rev ($35M) (0 disclosures) for PMAX.

VRXA and PMAX trade at balanced relative valuation multiples. VRXA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PMAX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-17.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VRXA (N/A ROE) versus PMAX (-101.8% ROE) capital efficiency.

In options market volatility and institutional positioning, VRXA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.16β · 104% Vol realized risk). By comparison, PMAX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (10.65β · 239% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.